Healthcare Services Group director gets stock grant

Healthcare Services Group Inc. director Laura K. Grant received a stock-based board fee grant.

Rhea-AI Filing Summary

Healthcare Services Group Inc. director Laura K. Grant received a stock-based board fee grant. On this Form 4, she acquired 405 shares of common stock at $18.55 per share as a grant or award, bringing her direct holdings to 16,039 shares.

According to the footnotes, she elected in 2025 to receive fully vested Deferred Stock Units (DSUs) under the 2020 Amended Omnibus Incentive Plan instead of cash fees for 2026 board service, consistent with blackout guidelines. Her position includes 2,806 unvested DSUs and 13,233 vested DSUs, which will be settled in common stock 90 days after she leaves the board, with an option for further deferral under Code Section 409A.

Insider Trade Summary 10b5-1

Grant/Award: 405 shares

Grant/Award 1 txn

Insider Grant Laura K

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	405	$18.55	$8K

Holdings After Transaction: Common Stock — 16,039 shares (Direct)

Footnotes (2)

1. F1. The reporting person has elected to receive fully vested shares of Deferred Stock Units ("DSUs") under the Issuer's 2020 Amended Omnibus Incentive Plan in lieu of cash fees payable for service on the Issuer's Board of Directors and any committees thereof. The reporting person made this election in 2025 which applies to the director's fees earned in 2026 in compliance with the issuer's black-out period guidelines. The number of shares represents the quotient of the amount of such fees divided by the issuer's closing stock price on the date such fees would otherwise be paid, rounded up to the nearest whole share. Such DSUs will be settled in shares of common stock ninety days following separation of service from the Board. The reporting person may elect a further deferral beyond the Settlement Date pursuant to the rules of Code Section 409A.
2. F2. Amount represents 2,806 unvested DSUs and 13,233 vested DSUs.

Key Figures

Shares granted: 405 shares Grant price: $18.55 per share Total shares after transaction: 16,039 shares +3 more

6 metrics

Shares granted 405 shares Common Stock grant/award on 2026-03-31

Grant price $18.55 per share Price per share for 405-share grant

Total shares after transaction 16,039 shares Direct holdings following the grant

Unvested DSUs 2,806 units Unvested Deferred Stock Units held

Vested DSUs 13,233 units Vested Deferred Stock Units held

DSU settlement timing 90 days Settlement after separation from the Board

Key Terms

Deferred Stock Units ("DSUs"), 2020 Amended Omnibus Incentive Plan, black-out period guidelines, Code Section 409A

4 terms

Deferred Stock Units ("DSUs") financial

"The reporting person has elected to receive fully vested shares of Deferred Stock Units ("DSUs") under the Issuer's 2020 Amended Omnibus Incentive Plan"

2020 Amended Omnibus Incentive Plan financial

"Deferred Stock Units ("DSUs") under the Issuer's 2020 Amended Omnibus Incentive Plan in lieu of cash fees"

black-out period guidelines regulatory

"applies to the director's fees earned in 2026 in compliance with the issuer's black-out period guidelines"

Code Section 409A regulatory

"The reporting person may elect a further deferral beyond the Settlement Date pursuant to the rules of Code Section 409A."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did the HCSG Form 4 for Laura K. Grant report?

It reported that director Laura K. Grant acquired 405 shares of Healthcare Services Group common stock as a grant or award at $18.55 per share, increasing her direct holdings to 16,039 shares including vested and unvested DSUs.

How many HCSG shares did Laura K. Grant receive and at what price?

She received 405 shares of Healthcare Services Group common stock at $18.55 per share. These shares represent board fees paid in stock under her election to receive fully vested DSUs instead of cash compensation for 2026 board service.

How many Deferred Stock Units does Laura K. Grant hold at HCSG?

She holds 2,806 unvested Deferred Stock Units and 13,233 vested Deferred Stock Units. All DSUs relate to Healthcare Services Group and will be settled in shares of common stock based on plan rules tied to her board service and separation date.

When will Laura K. Grant’s HCSG DSUs be settled into common shares?

Her Deferred Stock Units will be settled in Healthcare Services Group common stock 90 days after she separates from the board. The footnotes also state she may elect to defer settlement further under the rules of Internal Revenue Code Section 409A.

What compensation choice did Laura K. Grant make regarding HCSG board fees?

She elected in 2025 to receive fully vested DSUs under Healthcare Services Group’s 2020 Amended Omnibus Incentive Plan instead of cash fees for 2026 board and committee service, with share amounts based on the issuer’s closing stock price when fees would otherwise be paid.

How are Laura K. Grant’s HCSG board fees converted into DSU shares?

The number of DSU shares equals her board and committee fees divided by Healthcare Services Group’s closing stock price on the payment date, rounded up to the nearest whole share, as described in the footnote to the Form 4 filing for this transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/02/2026 - 04:28 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Grant Laura K

(Last) (First) (Middle)

3220 TILLMAN DRIVE

SUITE 300

(Street)

BENSALEM PENNSYLVANIA 19020

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
HEALTHCARE SERVICES GROUP INC [ HCSG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/31/2026		A		405	A	$18.55(1)	16,039(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reporting person has elected to receive fully vested shares of Deferred Stock Units ("DSUs") under the Issuer's 2020 Amended Omnibus Incentive Plan in lieu of cash fees payable for service on the Issuer's Board of Directors and any committees thereof. The reporting person made this election in 2025 which applies to the director's fees earned in 2026 in compliance with the issuer's black-out period guidelines. The number of shares represents the quotient of the amount of such fees divided by the issuer's closing stock price on the date such fees would otherwise be paid, rounded up to the nearest whole share. Such DSUs will be settled in shares of common stock ninety days following separation of service from the Board. The reporting person may elect a further deferral beyond the Settlement Date pursuant to the rules of Code Section 409A.

2. Amount represents 2,806 unvested DSUs and 13,233 vested DSUs.

Remarks:

	Michael Harrity, by Power of Attorney	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)